Yangyang Wang1, Yi Wang2, Jihan Wang3. 1. School of Electronics and Information, Northwestern Polytechnical University, Xi'an, China. 2. School of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, China. 3. Institute of Medical Research, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, 710072, Shaanxi, China. jihanwang@nwpu.edu.cn.
Abstract
PURPOSE: Human microbiome has been considered as the second genome of our body. The intratissue/intratumor microbiome analysis is a relatively new field and deserves more attention. In this study, we conducted a comprehensive analysis of microbiome signatures of head and neck squamous cell carcinoma (HNSC). METHODS: The intratumor microbiome profiling and clinicopathological information about a total of 177 HNSC samples, including 155 tumors and 22 adjacent normal tissues, were obtained from The Cancer Microbiome Atlas (TCMA) and The Cancer Genome Atlas (TCGA) databases. We identified the microbes that differed between tumors and normal tissues, and assessed their utility values as diagnostic biomarkers. The microbiome signatures under different conditions of clinicopathological parameters were also analyzed. RESULTS: The intratissue microbiome profiles differed between tumor and normal samples of HNSC. The composition of four, six, and six microbes changed in tumors compared to normal tissues at the phylum, order, and genus levels, respectively (P < 0.05). Eight of the differential microbes performed well in distinguishing tumors from normal tissues (AUC > 0.7, P ≤ 0.001). The microbiome signature was found to be associated with tumor clinicopathological characteristics such as host-gender, host-age, tumor stage, and neoplasm histologic grade. CONCLUSION: Overall, our results revealed an intratissue microbiome signature of HNSC. We concluded that the intratumor microbiome signature may also reflect human biology in both healthy and disease status, and provide novel perspective for microbiota research about their roles in tumors.
PURPOSE: Human microbiome has been considered as the second genome of our body. The intratissue/intratumor microbiome analysis is a relatively new field and deserves more attention. In this study, we conducted a comprehensive analysis of microbiome signatures of head and neck squamous cell carcinoma (HNSC). METHODS: The intratumor microbiome profiling and clinicopathological information about a total of 177 HNSC samples, including 155 tumors and 22 adjacent normal tissues, were obtained from The Cancer Microbiome Atlas (TCMA) and The Cancer Genome Atlas (TCGA) databases. We identified the microbes that differed between tumors and normal tissues, and assessed their utility values as diagnostic biomarkers. The microbiome signatures under different conditions of clinicopathological parameters were also analyzed. RESULTS: The intratissue microbiome profiles differed between tumor and normal samples of HNSC. The composition of four, six, and six microbes changed in tumors compared to normal tissues at the phylum, order, and genus levels, respectively (P < 0.05). Eight of the differential microbes performed well in distinguishing tumors from normal tissues (AUC > 0.7, P ≤ 0.001). The microbiome signature was found to be associated with tumor clinicopathological characteristics such as host-gender, host-age, tumor stage, and neoplasm histologic grade. CONCLUSION: Overall, our results revealed an intratissue microbiome signature of HNSC. We concluded that the intratumor microbiome signature may also reflect human biology in both healthy and disease status, and provide novel perspective for microbiota research about their roles in tumors.
Authors: Ian Ganly; Liying Yang; Rachel A Giese; Yuhan Hao; Carlos W Nossa; Luc G T Morris; Matthew Rosenthal; Jocelyn Migliacci; Dervla Kelly; Wenzhi Tseng; Jiyuan Hu; Huilin Li; Stuart Brown; Zhiheng Pei Journal: Int J Cancer Date: 2019-02-19 Impact factor: 7.396
Authors: Beth A Helmink; M A Wadud Khan; Amanda Hermann; Vancheswaran Gopalakrishnan; Jennifer A Wargo Journal: Nat Med Date: 2019-03-06 Impact factor: 53.440
Authors: Asad A Haider; Michael J Marino; William C Yao; Martin J Citardi; Amber U Luong Journal: Otolaryngol Head Neck Surg Date: 2019-08-06 Impact factor: 3.497
Authors: Richard B Hayes; Jiyoung Ahn; Xiaozhou Fan; Brandilyn A Peters; Yingfei Ma; Liying Yang; Ilir Agalliu; Robert D Burk; Ian Ganly; Mark P Purdue; Neal D Freedman; Susan M Gapstur; Zhiheng Pei Journal: JAMA Oncol Date: 2018-03-01 Impact factor: 31.777
Authors: Anders B Dohlman; Diana Arguijo Mendoza; Shengli Ding; Michael Gao; Holly Dressman; Iliyan D Iliev; Steven M Lipkin; Xiling Shen Journal: Cell Host Microbe Date: 2021-01-06 Impact factor: 21.023